Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

61. Effectiveness of anticoagulant therapy for antiphospholipid syndrome: a systematic review of randomised trials with focus on outcome reporting

Effectiveness of anticoagulant therapy for antiphospholipid syndrome: a systematic review of randomised trials with focus on outcome reporting Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

62. Effectiveness and harms of anti-aggregating therapy compared with anticoagulation therapy in patients with blunt carotid injury to lower stroke, bleeding and mortality risk: systematic review and meta-analysis

Effectiveness and harms of anti-aggregating therapy compared with anticoagulation therapy in patients with blunt carotid injury to lower stroke, bleeding and mortality risk: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD

2019 PROSPERO

63. Effectiveness of hemostatic protocols for prevention of bleeding in oral procedures in anticoagulated individuals. A systematic review and meta-analysis

Effectiveness of hemostatic protocols for prevention of bleeding in oral procedures in anticoagulated individuals. A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

64. Anti-platelets versus anticoagulants after left atrial occlusion devices: systematic review and meta-analysis

Anti-platelets versus anticoagulants after left atrial occlusion devices: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

65. Oral anticoagulants compared to antiplatelet or placebo in adult patients with chronic heart failure in sinus rhythm and reduced ejection fraction: a systematic review

Oral anticoagulants compared to antiplatelet or placebo in adult patients with chronic heart failure in sinus rhythm and reduced ejection fraction: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

66. The interactions between anticonvulsants and novel oral anticoagulants in patients: a systematic review

The interactions between anticonvulsants and novel oral anticoagulants in patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

67. The efficacy and safety of oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism (VTE) in hematologic malignancies: a systematic review and meta-analysis

The efficacy and safety of oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism (VTE) in hematologic malignancies: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

68. What is the most clinically and cost-effective anticoagulant therapy for stroke prevention in people with atrial fibrillation?

What is the most clinically and cost-effective anticoagulant therapy for stroke prevention in people with atrial fibrillation? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

69. Drug-drug interactions of novel (direct) oral anticoagulants in clinical settings - a systematic review

Drug-drug interactions of novel (direct) oral anticoagulants in clinical settings - a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

70. Medication errors associated with non-vitamin K antagonist oral anticoagulants (NOACs) in adult patients

Medication errors associated with non-vitamin K antagonist oral anticoagulants (NOACs) in adult patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

71. Safety and efficacy of direct oral anticoagulants in cancer patient with atrial fibrillation. A systematic review and meta-analysis

Safety and efficacy of direct oral anticoagulants in cancer patient with atrial fibrillation. A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

72. Specialized anticoagulation management service care compared with no specialized anticoagulation management service care provided by the patient's physician for patients receiving anticoagulation therapy: systematic review and meta-analysis

Specialized anticoagulation management service care compared with no specialized anticoagulation management service care provided by the patient's physician for patients receiving anticoagulation therapy: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission

2019 PROSPERO

73. Anticoagulation control in patients on vitamin K antagonists in Africa: a systematic review

Anticoagulation control in patients on vitamin K antagonists in Africa: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

74. Direct oral anticoagulant compared to low molecular weight heparin in the treatment of venous thromboembolism in patients with cancer: a systematic review and meta-analysis of randomized controlled trials

Direct oral anticoagulant compared to low molecular weight heparin in the treatment of venous thromboembolism in patients with cancer: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

75. Adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation

Adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

76. Catheter assisted thrombolysis plus anticoagulation or anticoagulation alone for treating patients with iliofemoral vein thrombosis: a meta-analysis of randomized trials

Catheter assisted thrombolysis plus anticoagulation or anticoagulation alone for treating patients with iliofemoral vein thrombosis: a meta-analysis of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

77. Anticoagulants for thromboprophylaxis in ambulatory patients with cancer

Anticoagulants for thromboprophylaxis in ambulatory patients with cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

78. Adherence to oral anticoagulants for treatment of atrial fibrillation in the Middle East: a systematic review

Adherence to oral anticoagulants for treatment of atrial fibrillation in the Middle East: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

79. Meta-analysis of minimally interrupted non-vitamin K oral anticoagulants versus uninterrupted use of non-vitamin K oral anticoagulants in atrial fibrillation catheter ablation

Meta-analysis of minimally interrupted non-vitamin K oral anticoagulants versus uninterrupted use of non-vitamin K oral anticoagulants in atrial fibrillation catheter ablation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

80. Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis [Cochrane protocol]

Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO